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doi:10.1016/j.jds.2012.03.012Abstract Background: Our aim was to investigate the prevalence, size, locations, and shapes
of torus palatinus (TP) in end-stage renal disease (ESRD) patients receiving peritoneal dialysis
(PD) in order to analyze the relationship between the TP size and duration of PD.
Materials and methods: During 2007, 91 ESRD patients receiving PD were studied using dental
examinations at our outpatient clinic.
Results: The prevalence of TP was 41.7% (nZ 38). Most cases of TP were < 2 cm in size (81.6%)
and spindle-shaped (78.9%). The duration of PD was statistically higher in patients with TP size
> 2 cm (6.8 3.6 years) than patients with TP size of < 2 cm (3.5 2.6 years).
Conclusions: The higher prevalence of TP and different TP shape (spindle) in comparison with
our previous study and the significant relationship between duration of PD and TP size might be
due to an underlying disorder, such as renal osteodystrophy.
Copyright ª 2012, Association for Dental Sciences of the Republic of China. Published by
Elsevier Taiwan LLC. All rights reserved.of Dentomaxillofacial Radi-
University, Kayseri 38039,
om (Y. Sisman).
iation for Dental Sciences of the ReIntroduction
Torus palatinus (TP) is an exostosis of the hard palate that is
localized along the median palatine suture and involves
both the processi palatini and os palatinum. TP contains
compact and cancellous bone and is formed by hypertrophypublic of China. Published by Elsevier Taiwan LLC. All rights reserved.





(%) (48.8) (35.4) 0.195
TP in ESRD with PD 155of the spongy and oral compact layers, while the nasal
compact layer remains unchanged.1 TP is asymptomatic,
grows slowly during the second and third decades of life,
and often goes unnoticed until middle age.2,3 Although
a lot of research has tried to clarify the influence of
genetic, environmental, nutritional, and climatologic
factors, there is still no consensus regarding the etiology of
TP.1,2,4,5 TP occurs in about 20% of the population.
However, some studies have reported marked differences
between racial groups.1 Its prevalence has been reported
to be 4.1e30.9% of the Turkish population.6e8 It has also
been reported that females demonstrate a higher preva-
lence of TP.2,3,6,9,10
Chronic renal failure is associated with a decrease in the
glomerular filtration rate. It is a progressive disease char-
acterized by the increasing inability of the kidneys to
function, ultimately causing end-stage renal disease (ESRD).
Abnormal calcium (Ca), phosphorus (P), and vitamin D
metabolism are very common in patients with ESRD.11e13
Metabolic disturbances in these patients result in the pro-
longed stimulation of the parathyroid glands. This results
in the increased synthesis and release of parathyroid
hormone (PTH); therefore, it causes parathyroid hyper-
plasia/secondary hyperparathyroidism (SHPT). SHPT causes
the skeletal disturbances that are characteristic of renal
osteodystrophy (RO).13e17
In the present study, our aim was to investigate the
prevalence, size, locations, and shapes of TP in ESRD
patients undergoing peritoneal dialysis (PD) and analyze the
relationship between the TP size and duration of PD.
According to a search of the medical literature, this is the
first study to evaluate TP in ESRD patients.
Materials and methods
In 2007, 91 ESRD patients with PD were received dental
examinations at the Department of Dentomaxillofacial
Radiology, Faculty of Dentistry, Erciyes University (Kayseri,
Turkey). All of these patients were examined by the senior
author (Y.S.) to determine the presence of TP. The exam-
ination for TP consisted of clinical inspection and palpa-
tion, which were performed by the same author. Patients
who had questionable TP status were not included in this
study. For diagnosis, TP was defined as a raised bony
exostosis along the midline of the hard palate. The
maximum elevation of the outgrowth of TP, which is
usually consistent with the width and length of TP,18 was
used to measure the size of TP. TP was graded according to
a previous description8 as being > 2 cm or < 2 cm using
a periodontal probe, as described by Gorsky et al.19 The
shape of TP was classified as flat, spindle, nodular, or
lobular according to the criteria described by Jainkittivong
et al.9 The TP locations were classified as being in the
incisor, incisor-premolar, premolar-molar, molar, or
incisor-premolar-molar regions. The duration of PD was
noted for each patient.
Statistical analyses
The observed results were analyzed using SPSS 15.0
(SPSS, Chicago, IL, USA). The Chi-square test and t testwere used to analyze group differences. P values < 0.05
were considered statistically significant.
Results
Ninety-one ESRD patients receiving PD were enrolled in the
present study. This study enrolled 43 females and 48 males
with a mean age of 45.9 13.1 years (range: 19e81 years).
No significant difference in terms of the mean age between
females (44.3 14.4 years) and males (47.3 11.8 years)
was detected (PZ 0.278).
Table 1 presents the distribution of TP in relation to the
genders of these patients. Of the 91 patients with ESRD, 38
(41.7%) were found to have TP. The 38 individuals with TP
included 21 females and 17 males, demonstrating a female-
to-male ratio of 1.4:1 for TP. The prevalence of TP was not
significantly higher in female patients (48.8%) compared
with the male patients (35.4%) (PZ 0.195).
The distribution of TP size according to gender, age, and
duration of PD is shown in Table 2. Of the 38 TP cases, most
(81.6%) were < 2 cm in size. No significant difference in
terms of the mean age was found between patients with
a TP size > 2 cm (45.6 13.3 years) and those with a TP size
< 2 cm (43.6 13.6 years) (PZ 0.731). The duration of PD
was statistically higher in patients with a TP size > 2 cm
(6.8 3.6 years) than those with a TP size < 2 cm (3.5 2.6
years) (PZ 0.009) (Fig. 1).
Table 3 shows the TP locations along the hard palate of
these 38 patients. The most common site where TP was
found was the premolar-molar region (44.7%), followed by
the premolar (26.3%) and incisor-premolar regions (21.1%).
A less common location was the incisor-premolar-molar
region (7.9%).
Table 4 shows the distribution of TP according to shape
and in relation to gender. The most common TP shape was
spindle (78.9%). A less common TP shape was flat (21.1%).
However, none of these cases of TP were classified as
nodular or lobular.
Discussion
TP is a bony prominence that occurs along the middle third
of the midline of the hard palate. It forms different shapes,
including flat, spindle, nodular, and lobular.1,9,20 This oral
exostosis is not a disease or a sign of disease. However, if TP
is large, it may be problematic for the construction or
wearing of dentures.20 Although, TP is not pathologically
significant, surgical removal is required if it causes chronic
trauma or interferes with oral function or the replacement
of a denture base or framework.18,20 Although several
Table 2 Distribution of TP in relation to size, gender, age, and duration of PD.
TP size Women (nZ 21) Men (nZ 17) Total (nZ 38) Age (y) Duration of PD (y)
< 2 cm 16 15 31 45.6 13.3 3.5 2.6
(%) (76.2) (88.2) (81.6)
> 2 cm 5 2 7 43.7 13.0 6.8 3.6
(%) (23.8) (11.8) (18.4)
P 0.731 0.009
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genetic, environmental, nutritional, and climatologic
factors, the exact etiology of TP is still unknown.2,4,5,21
Abnormal Ca, P, and vitamin D metabolism are very
common in patients with ESRD.11e13 Metabolic disturbances
in these patients cause the prolonged stimulation of the
parathyroid glands. This results in the increased synthesis
and release of PTH; therefore, it causes parathyroid
hyperplasia-SHPT. SHPT develops as a result of hypocal-
cemia, hyperphosphatemia, and reduced 1,25-
dihydroxyvitamin D3 (vitamin D) production. SHPT also
causes the skeletal disturbances that characterize RO.12e17
RO is classified as osteitis fibrosa, osteomalacia, or mixed,
mild, or adynamic disease.13
TP occurs in about 20% of the population, although
different studies have reported marked differences
between various ethnic groups.2,7,8,10,22e24 However, to the
best of our knowledge, no study is available in the litera-
ture that investigated the prevalence of TP in patients with
ESRD. In a Turkish study,8 the prevalence of TP was 30.9%
among 1943 school children (range: 5e15 years old). Cagi-
rankaya et al7 pointed out that the prevalence of TP was
20.9% among 253 consecutive patients (range: 17e49 years
old). In another study, Sisman et al6 investigated 2660
Turkish patients (range: 13e85 years old) who were
admitted to a dental clinic for routine examinations and
reported the prevalence of TP in the Cappadocia region to
be 4.1%.6 In the present report, the prevalence was 41.7%
among 91 patients with ESRD in the same region. The
marked difference between the prevalences reported in
these two studies might be due to an underlying disorder,
such as RO, and not the small sample size.
These different prevalences between different pop-
ulations may be due to the different ethnicities that were
studied. It has been reported that similar ethnic groups
living in different areas10,23 and different ethnic groupsFigure 1 Age and duration of PD in relation to TP size.living in the same areas19,25 demonstrate different preva-
lences of TP. The formation of TP has been attributed to
various factors by different authors. Several investigators
evaluated the effects of environmental11,21 and genetic
factors,2,5 including masticatory stress4,26 and nutritional
factors.10 The prevalence of TP within the same race has
been reported to vary greatly by different authors.6e8
These inconsistent results between various studies are
possibly due to differences in the number of subjects,
different geographic locations, and different diagnostic
criteria for TP.
Dietary factors may play a role in the prevalence of tori.
Eggen and Natvig27 investigated the influence of nutrients
on the etiology of tori. It was suggested that the
consumption of saltwater fish in Norway possibly supplies
higher levels of polyunsaturated fatty acids and vitamin D,
which are involved in bone growth, and this may increase
the prevalence of tori. Gorsky et al2 investigated the
inheritance of TP using segregation analysis. Their results
suggest that TP is an autosomal dominant trait. Belsky
et al20 reported that the presence and especially the size of
TP are correlated with increased bone mineral density. A
high bone mass may be associated with genetic mutations.
Genetic factors are a probable cause of the low TP preva-
lence among the general Turkish population. Seafood
consumption is not as common in central Anatolia (Cappa-
docia region) as in other parts of the world that have more
abundant water resources. These factors may explain the
low TP prevalence (4.1%) among the Turkish population
living in the Cappadocia region.6
In our study, 91 ESRD patients receiving PD living in the
same region demonstrated a TP prevalence of 41.7%.
Abnormal Ca, P, and vitamin D metabolism are very
common in patients with ESRD.11e13 SHPT and reduced
vitamin D production also cause RO.12e17 Therefore,
instead of reduced vitamin D production, the high preva-
lence of ESRD patients receiving PD in this region might be
due to SHPT (osteitis fibrosa). However, further studies and












n 8 10 17 0 3
(%) (21.1) (26.3) (44.7) (0.0) (7.9)
I, incisor; P, premolar; M, molar.
Table 4 Distribution of TP shape in relation to gender.
TP shape Women Men Total
(nZ 21) (nZ 17) (nZ 38)
Flat 6 2 8
(%) (28.6) (11.8) (21.1)
Spindle 15 15 30
(%) (71.4) (88.2) (78.9)
Nodular 0 0 0
(%) (0.0) (0.0) (0.0)
Lobular 0 0 0
(%) (0.0) (0.0) (0.0)
TP in ESRD with PD 157In the study by Sisman et al,6 the prevalence of TP was
significantly higher among women (5.7%) than men (1.8%) in
the general Turkish population living in the Cappadocia
region (P< 0.001). In the present study, the female-to-
male ratio was 1.4:1 for TP in patients with ESRD. In this
study, the ratio difference between the normal population
and ESRD patients in the same region might be due to an
underlying disorder rather than the small sample size. The
findings of our study, namely that the prevalence of TP is
higher in females than males, is consistent with other
studies.2,4,6e10,18,22,25,26 There is no certain explanation for
this difference, but genetics could be a major factor.
In the study by Sisman et al,6 most cases of TP (75.4%)
were < 2 cm and were located in the premolar-molar area
(66.4%). Yildiz et al8 reported that 91.5% of TP cases are <
2 cm and 62% are located in the molar area among 5e15-
year-olds. This suggests that the prevalence of TP in the
molar and molar-premolar areas tends to increase with age.
King and More,28 who studied 400 individuals in the United
States and United Kingdom, reported that 67% of TP cases
are < 2 cm. In the current study, most cases of TP (81.6%)
were < 2 cm, and the majority (44.7%) of these cases were
located in the premolar-molar area of ESRD patients
receiving PD. These findings are consistent with the study
by Sisman et al.6 We also investigated the relationship
between the duration of PD and TP size. We found that the
duration of PD was statistically higher in patients with a TP
size > 2 cm (6.8 3.6 years) than patients with a TP size <
2 cm (3.5 2.6 years) (PZ 0.009). This significant differ-
ence might have been due to an underlying disorder, such
as RO, in these patients.
Most studies24,29,30 agree with the study by Sisman et al6
and report that flat TP is the most common type, but the
studies by Reichart et al5 and Jainkittivong et al9 reported
spindle-shaped TPs. However, in the present study, the
most common type was spindle-shaped TP (78.9%) in
contrast with the study by Sisman et al6 that reported flat
TP as the most common (62.7%). This difference in TP type
between these two studies, which were conducted in the
same region, might be due to an underlying disorder such
as RO.
In conclusion, the prevalence of TP in ESRD patients
undergoing PD was higher (41.7%) compared with other
Turkish reports and, most especially, the study by Sisman
et al6 (4.1%), which was performed in the same region but
in the general population. Our results demonstrate
a significant relationship between TP size and duration ofPD. Most cases of TP were classified as spindle-shaped
(78.9%), < 2 cm in size (81.6%), and located in the
premolar-molar region (44.7%). The high prevalence of TP
and different TP shape (spindle) compared with the study
by Sisman et al6 might be due to an underlying disorder,
such as RO. Also, the significant relationship between
duration of PD and TP size might be due to ESRD. To the
best of our knowledge, this is the first study to be con-
ducted that investigated the prevalence of TP among ESRD
patients undergoing PD.
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